Skip to main content
. 2020 Jan 20;2020:4347676. doi: 10.1155/2020/4347676

Table 2.

Comparison of TVW, AIS, VFT, and TMT in the VaD, VCIND, and NCI patients (x¯ ± s).

Group Treatment time TVW AIS VFT TMT
VaD (n = 40) Before treatment 0.96 ± 0.23 1.52 ± 0.49 10.27 ± 3.17 123.63 ± 57.73
After 6 months of treatment 0.93 ± 0.21 1.36 ± 0.38 12.46 ± 2.19 122.15 ± 45.38
After 12 months of treatment 0.84 ± 0.19 1.63 ± 0.11 15.13 ± 2.14 120.77 ± 54.69
VCIND (n = 40) Before treatment 0.91 ± 0.22 1.68 ± 0.39 11.14 ± 3.12 123.55 ± 56.87
After 6 months of treatment 0.88 ± 0.21 1.57 ± 0.27 13.03 ± 2.06 121.89 ± 45.44
After 12 months of treatment 0.82 ± 0.18 1.21 ± 0.63 16.44 ± 2.16 120.32 ± 54.76
NCI (n = 40) Before treatment 0.80 ± 0.19 1.79 ± 0.41 15.03 ± 3.06 123.46 ± 46.35
After 6 months of treatment 0.81 ± 0.17 1.80 ± 0.24 15.75 ± 2.04 115.57 ± 55.01
After 12 months of treatment 0.79 ± 0.16 1.87 ± 0.36 16.72 ± 2.13 111.47 ± 45.32
F/P VaD group value 0.163/0.028 0.325/0.003 0.754/0.003 0.855/0.016
F/P VCIND group value 0.174/0.005 0.542/0.018 0.584/0.027 0.585/0.027
F/P NCI group value 0.164/0.002 0.234/0.003 0.234/0.015 0.584/0.005
t/P 6 months treatment group value 0.471/0.013 0.422/0.014 0.742/0.003 0.234/0.023
t/P 12 months treatment group value 0.315/0.001 0.512/0.032 0.284/0.002 0.679/0.015